Jinxin Fertility Group 将来の成長

Future 基準チェック /36

Jinxin Fertility Group利益と収益がそれぞれ年間19.4%と10.8%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に5.1% 19.3%なると予測されています。

主要情報

19.4%

収益成長率

19.3%

EPS成長率

Healthcare 収益成長	18.5%
収益成長率	10.8%
将来の株主資本利益率	5.1%
アナリストカバレッジ	Good
最終更新日	21 Nov 2024

今後の成長に関する最新情報

更新なし

Recent updates

業績と収益の成長予測

SHSC:1951 - アナリストの将来予測と過去の財務データ ( )CNY Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	3,910	558	686	975	14
12/31/2025	3,505	476	682	886	17
12/31/2024	3,049	406	385	724	12
6/30/2024	2,899	311	560	731	N/A
3/31/2024	2,844	328	536	708	N/A
12/31/2023	2,789	345	511	684	N/A
9/30/2023	2,675	250	495	645	N/A
6/30/2023	2,560	155	480	606	N/A
3/31/2023	2,462	138	31	574	N/A
12/31/2022	2,364	121	-418	542	N/A
9/30/2022	2,241	248	-479	492	N/A
6/30/2022	2,118	374	-541	442	N/A
3/31/2022	1,978	357	-139	393	N/A
12/31/2021	1,839	340	264	343	N/A
9/30/2021	1,756	316	190	374	N/A
6/30/2021	1,674	291	117	405	N/A
3/31/2021	1,550	271	51	356	N/A
12/31/2020	1,426	252	-15	308	N/A
9/30/2020	1,448	304	-21	295	N/A
6/30/2020	1,469	356	-27	281	N/A
3/31/2020	1,559	383	74	367	N/A
12/31/2019	1,648	410	175	453	N/A
9/30/2019	1,475	339	302	457	N/A
6/30/2019	1,301	269	428	461	N/A
3/31/2019	1,112	218	382	409	N/A
12/31/2018	922	167	335	356	N/A
12/31/2017	663	99	N/A	48	N/A
12/31/2016	346	88	N/A	109	N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1951の予測収益成長率 (年間19.4% ) は貯蓄率 ( 2.3% ) を上回っています。

収益対市場: 1951の収益 ( 19.4% ) はHong Kong市場 ( 11.6% ) よりも速いペースで成長すると予測されています。

高成長収益: 1951の収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: 1951の収益 ( 10.8% ) Hong Kong市場 ( 7.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: 1951の収益 ( 10.8% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 1951の自己資本利益率は、3年後には低くなると予測されています ( 5.1 %)。

Jinxin Fertility Group 将来の成長

Future 基準チェック /36

主要情報

今後の成長に関する最新情報

Recent updates

Investor sentiment deteriorates as stock falls 25%

Investor sentiment improves as stock rises 18%

First half 2024 earnings released: EPS: CN¥0.071 (vs CN¥0.084 in 1H 2023)

Jinxin Fertility Group Limited to Report First Half, 2024 Results on Aug 29, 2024

Investor sentiment deteriorates as stock falls 18%

Upcoming dividend of HK$0.059 per share

Investor sentiment improves as stock rises 15%

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited, Annual General Meeting, Jun 25, 2024

Full year 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.049 in FY 2022)

Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 July 2024

Jinxin Fertility Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024

Investor sentiment improves as stock rises 15%

Non-Executive Director recently bought HK$2.0m worth of stock

Co-CEO & Executive Director recently bought HK$3.6m worth of stock

Investor sentiment deteriorates as stock falls 17%

Jinxin Fertility Group Limited Announces Change of Chief Financial Officer

First half 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.076 in 1H 2022)

Jinxin Fertility Group Limited to Report First Half, 2023 Results on Aug 29, 2023

Co-CEO & Executive Director recently bought HK$7.8m worth of stock

Full year 2022 earnings released: EPS: CN¥0.049 (vs CN¥0.14 in FY 2021)

Investor sentiment deteriorates as stock falls 18%

Now 23% undervalued

Jinxin Fertility Group Limited has completed a Follow-on Equity Offering in the amount of HKD 1.176875 billion.

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment improved over the past week

Chairman of the Board recently bought HK$6.5m worth of stock

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.063 in 1H 2021)

Jinxin Fertility Group Limited to Report First Half, 2022 Results on Aug 31, 2022

Jinxin Fertility Group Limited Declares Final Dividend for the Year Ended December 31, 2021

Investor sentiment improved over the past week

Upcoming dividend of HK$0.074 per share

Investor sentiment improved over the past week

Jinxin Fertility Group Limited, Annual General Meeting, Jun 28, 2022

CO-CEO & Executive Director recently bought HK$15m worth of stock

Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.14 (vs CN¥0.10 in FY 2020)

Jinxin Fertility Group Limited Proposes Final Dividend for the Year Ended December 31, 2021, Payable on July 22, 2022

Investor sentiment deteriorated over the past week

CEO & Executive Director recently bought HK$1.9m worth of stock

CEO & Executive Director recently bought HK$1.0m worth of stock

First half 2021 earnings released: EPS CN¥0.063 (vs CN¥0.048 in 1H 2020)

Independent Non-Executive Director Haw Kuang Lim has left the company

Joint Company Secretary Suet Wing Leung has left the company

CEO & Executive Director recently bought HK$6.2m worth of stock

Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019)

Chairman of the Board Bin Wang has left the company

Full year 2020 earnings released: EPS CN¥0.10 (vs CN¥0.19 in FY 2019)

Jinxin Fertility Group Limited to Report Q4, 2020 Results on Mar 28, 2021

New 90-day high: HK$19.40

New 90-day high: HK$17.22

New 90-day high: HK$15.80

New 90-day high: HK$15.04

Market bids up stock over the past week

Market bids up stock over the past week

Market bids up stock over the past week

New 90-day high: HK$11.80

New 90-day low: HK$9.65

First half earnings released

New 90-day low: HK$9.76

First half earnings released

Jinxin Fertility Group Limited to Report First Half, 2020 Results on Aug 31, 2020

Jinxin Fertility Group Limited Announces Management Changes

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘